TY - JOUR
T1 - MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy
AU - Becker, Lore
AU - Kling, Eva
AU - Schiller, Evelyn
AU - Zeh, Ramona
AU - Schrewe, Anja
AU - Hölter, Sabine M.
AU - Mossbrugger, Ilona
AU - Calzada-Wack, Julia
AU - Strecker, Valentina
AU - Wittig, Ilka
AU - Dumitru, Iulia
AU - Wenz, Tina
AU - Bender, Andreas
AU - Aichler, Michaela
AU - Janik, Dirk
AU - Neff, Frauke
AU - Walch, Axel
AU - Quintanilla-Fend, Leticia
AU - Floss, Thomas
AU - Bekeredjian, Raffi
AU - Gailus-Durner, Valérie
AU - Fuchs, Helmut
AU - Wurst, Wolfgang
AU - Meitinger, Thomas
AU - Prokisch, Holger
AU - De Angelis, Martin Hrabě
AU - Klopstock, Thomas
N1 - Publisher Copyright:
© 2014 Becker et al.
PY - 2014/12/15
Y1 - 2014/12/15
N2 - Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients.
AB - Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients.
UR - http://www.scopus.com/inward/record.url?scp=84918553327&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0114918
DO - 10.1371/journal.pone.0114918
M3 - Article
C2 - 25506927
AN - SCOPUS:84918553327
SN - 1932-6203
VL - 9
JO - PLoS ONE
JF - PLoS ONE
IS - 12
M1 - e114918
ER -